glp-1/gip agonists Dual GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes Upcoming wave of hormone-based therapies
Description
Weight loss is a complex medical process that should always involve professional guidance
[Preprint] [DOI] [Google Scholar] 56.GLP-1 drug liraglutide may protect against dementia
Pediatric and Adolescent Obesity Treatment: Since FDA approval in 2022, GLP-1 receptor agonists have been prescribed for individuals aged 12 years and older with obesity (BMI 95th percentile)
E., Battaglia F., Hen R
